Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Daguo Mujiangzi Formula Granule is a Traditional Chinese Medicine (TCM) product developed by Guizhou Yibai Pharmaceutical. It is a standardized, concentrated extract derived from the plant *Litsea japonica* (known as Daguo Mujiangzi), intended to be dissolved in water for oral consumption. Guizhou Yibai was designated as a pilot enterprise for TCM formula granule research by the Guizhou Provincial Drug Administration in 2020. As a TCM formula granule, it represents a modern formulation of traditional herbal medicine, though specific clinical indications and its precise molecular mechanism of action have not been publicly disclosed in available pipeline documentation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on daguo mujiangzi formula granule.